Cell Migration and Cell Invasion Assay Market

Assay kits are estimated at 38.0% by product type in 2026 with cancer research at 42.0% and transwell assays at 37.0%. Adoption depends on controlled biology and consistent analysis as matrix variation can obscure cell-motility differences across laboratories.